How Vertex Pharmaceuticals Incorporated's share price moved after each results release, and its latest quarters.
Vertex Pharmaceuticals Incorporated has moved on average 3.18% (up or down) on the trading day after its last 4 results, and rose after 2 of its last 8. The biggest move was a fall of 20.6% on 5 Aug 2025. At today's price of $538.60, an average-sized move would be about $17.13 a share.
| Results filed | Opened | Closed |
|---|---|---|
| 2 Nov 2026 | +0.96% | -4.05% |
| 3 Aug 2026 | +0.12% | +1.70% |
| 4 May 2026 | +0.50% | -1.28% |
| 12 Feb 2026 | +1.42% | +5.69% |
| 3 Nov 2025 | -1.75% | -1.02% |
| 4 Aug 2025 | -13.56% | -20.60% |
| 5 May 2025 | -6.92% | -10.03% |
| 10 Feb 2025 | -2.16% | -3.14% |
Against the close before the release. A release before the 16:00 New York close counts that day; after the close, the next trading day.
| Quarter ended | Revenue | Profit | EPS |
|---|---|---|---|
| 30 Sept 2026 | $3.44 B | $654 M | $2.56 |
| 30 Jun 2026 | $3.33 B | $1.10 B | $4.31 |
| 31 Mar 2026 | $2.99 B | $1.03 B | $4.02 |
| 31 Dec 2025 | $3.19 B | $1.19 B | $4.64 |
| 30 Sept 2025 | $3.08 B | $1.08 B | $4.20 |
| 30 Jun 2025 | $2.96 B | $1.03 B | $3.99 |
| 31 Mar 2025 | $2.77 B | $646 M | $2.49 |
| 31 Dec 2024 | $2.91 B | $913 M | $3.62 |
From the company's SEC filings (10-Q and 10-K).
Vertex Pharmaceuticals Incorporated stock page › · Earnings calendar ›
Release times from SEC filings; next date and EPS estimate from Nasdaq's earnings calendar; prices from all US exchanges. Information only, not investment advice.
On average 3.18% (up or down) on the trading day after its last 4 results, from its SEC filing times and daily closes.
Not announced yet. Companies usually report about 3 to 6 weeks after each quarter ends.